Press Release

TGaS Advisors Launches Compliance Operations Benchmark (COPs)

Ambler, Penn., May 18, 2007 — TGaS^® Advisors announced the launch of a new collaborative benchmark focusing on pharmaceutical commercial operations compliance issues. Companies are currently being enrolled in TGaS’s Compliance Operations Practices, also known as COPs. This new benchmark will focus on how pharmaceutical companies are managing issues raised by increased oversight, including the Prescription Drug Marketing Act (PDMA), Office of the Inspector General (OIG) guidelines, Pharmaceutical Research and Manufacturers of America (PhRMA) guidelines, organizational structures and resources, compliance with state regulations and general compliance operations.

“This new benchmark was developed in response to clients’ requests to find the answer to a critical question in today’s heightened regulatory environment: ‘How do other pharmaceutical companies do ‘it’?^®’” said TGaS Managing Partner Stephen Gerard. “COPs will help them learn from aggregated information and insights how their peers are thinking about and handling this challenging issue.”

COPs joins the firm’s PHARMASTANCE^® family of operational benchmarks, which include Sales Operations Practices (SOPs), Specialty Sales Operations Practices (SSOPs), Internet Marketing Operations Practices (iMOPs), Marketing Operations Practices (MOPs), Marketing Sciences Operations Practices (MSOPs), District Manager Operations Practices (DMOPs) and Managed Markets Operations Practices (MMOPs).

As with other PHARMASTANCE benchmarks, COPs begins with information-gathering and in-depth personal interviews conducted by TGaS professionals. Companies participating in the collaborative peer-set receive confidential, unbiased blinded data and customized implementation recommendations based on this information. The results are not syndicated or made available outside the peer-set.

“We believe this new benchmark will enhance the high-level information available in the compliance arena by providing a greater depth and timeliness to the questions our clients are asking,” said Gerard. “Additionally, TGaS Advisors is looking at this benchmark within the context of the insights and operational benchmarks we have gained with our other solutions.”

About TGaS Advisors LLC

TGaS Advisors was founded in 2003 by industry professionals, each with more than 20 years of pharmaceutical experience. TGaS provides the only comprehensive, peer-set benchmark solutions for improving the strategy and effectiveness of pharmaceutical and biopharmaceutical operations. Because TGaS offers confidential advisory services only, clients can evaluate options based solely on their business needs. TGaS Advisors is based in Ambler, Pennsylvania, with an office in Princeton, N.J.

Other 2007:

TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies

TGaS Advisors Expands Staff to Accommodate Business Growth Robert Shewbrooks Joins Firm as Vice President, Management Advisor

TGaS Advisors Appoints Boucher to New Analytics, Outreach Position

TGaS Advisors Moves into New Corporate Headquarters

TGaS Advisors Hires Jeff Wojcik and Donna Wray